End of Year Message

Dear Partners and Friends of conect4children,

At the end of a year which brought a lot of change and uncertainty to the world around us, we would like to reflect on c4c´s achievements of the past year and to look forward to what lies ahead in the coming months.

Details

Prophylactic Intravenous Acetaminophen in Extremely Premature Infants: Minimum Effective Dose Research by Bayesian Approach

Patent ductus arteriosus (PDA) in preterm infants is associated with increased morbidities and mortality. Prophylactic treatment with cyclooxygenase inhibitors, as indomethacin or ibuprofen, failed to demonstrate significant clinical benefits. Acetaminophen may represent an alternative treatment option. To read full article, click here Related posts: c4c publication on efficient paediatric formulation development How c4c is improving…

Details

Fair Cookbook

We recently collaborated with FAIRPlus, another IMI funded project, as part of our WP5 data harmonization and standardization tasks to look at ways to make metadata collected about clinical trials more FAIR

Details

c4c Interview

At the c4c General Assembly meeting, we had the opportunity to talk to members of the new c4c legal entity management team

Details

Spotlight: POLPEDNET

The POLPEDNET network was established in 2017 due to initiative of Children’s Memorial Health Institute by representatives of four biggest paediatric hospitals in Poland

Details